Fibromyalgia: non-entity or double agent

被引：3

作者：

Eisinger, J ^{[1
]}

机构：

[1] Ctr Hosp Intercommunal, Serv Rhumatol & Med Geriatr, F-83056 Toulon, France

来源：

REVUE DE MEDECINE INTERNE | 2001年 / 22卷 / 09期

关键词：

fibromyalgia; diagnosis; algotensiometry;

D O I：

10.1016/S0248-8663(01)00431-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：809 / 811

页数：3

共 31 条

[1] REDUCED HIGH-ENERGY PHOSPHATE LEVELS IN THE PAINFUL MUSCLES OF PATIENTS WITH PRIMARY FIBROMYALGIA [J].

BENGTSSON, A ;

HENRIKSSON, KG ;

LARSSON, J .

ARTHRITIS AND RHEUMATISM, 1986, 29 (07) :817-821

[2]

Bennett R, 1996, J MUSCULOSKELET PAIN, V4, P35

[3]

Cathébras P, 1998, ANN MED INTERNE, V149, P406

[4] Should fibromyalgia last through the next century? [J].

Cathébras, P .

REVUE DE MEDECINE INTERNE, 2000, 21 (07) :577-579

[5]

CHAGNON A, 2000, CONCOURS MED, V122, P229

[6]

CORTET B, 1992, REV RHUM, V59, P497

[7]

DANNESKIOLDSAMS.B, 2001, MYALGIES S1, V2, P8

[8]

DUPOND JL, 1995, REV MED INTERNE, V16, pS27

[9] Fibromyalgia and doping agents? [J].

Eisinger, J ;

Dupond, JL .

REVUE DE MEDECINE INTERNE, 1996, 17 (12) :977-978

[10] Reactive oxygen species, antioxidant status and fibromyalgia [J].

Eisinger, J ;

Gandolfo, C ;

Zakarian, H ;

Ayavou, T .

JOURNAL OF MUSCULOSKELETAL PAIN, 1997, 5 (04) :5-15

← 1 2 3 4 →